| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/02/2008 | EP1871365A2 Methods for treating diseases through inhibition the function of molecular chaperones such as protein disulfide isomerases , pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents |
| 01/02/2008 | EP1871364A1 Methods for treating or preventing acute myelogenous leukemia |
| 01/02/2008 | EP1871359A1 Delaying the ageing process and disorders caused by ageing |
| 01/02/2008 | EP1871166A2 Cancer vaccines and therapeutic methods |
| 01/02/2008 | EP1553962A4 Combination chemotherapy with chlorotoxin |
| 01/02/2008 | EP1550675B1 Phospholipid derivative |
| 01/02/2008 | EP1539207A4 Treatment of cell proliferative disorders with chlorotoxin |
| 01/02/2008 | EP1526856B1 Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy |
| 01/02/2008 | EP1465614B1 A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
| 01/02/2008 | EP1458410B1 Process for preparation of a mRNA tumour antigen library |
| 01/02/2008 | EP1457492B1 Crystals of taxane derivative and process for their production |
| 01/02/2008 | EP1443942B1 Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonate, a cox-2 inhibitor and a taxol |
| 01/02/2008 | EP1435986B1 Igf-binding protein-derived peptide |
| 01/02/2008 | EP1416933B1 Substituted piperidines as modulators of the melanocortin receptor |
| 01/02/2008 | EP1406859B1 Substituted 4-aminocyclohexanol derivatives |
| 01/02/2008 | EP1317476B1 Reagents for cell selection and methods of use |
| 01/02/2008 | EP1278868B1 Mutated form of arginine deiminase |
| 01/02/2008 | EP1272161B1 Lipid-based drug delivery systems against parasitic infections |
| 01/02/2008 | EP1268404B1 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 01/02/2008 | EP1254130B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 01/02/2008 | CN101098959A Improved viral purification methods |
| 01/02/2008 | CN101098958A Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 01/02/2008 | CN101098873A 1,4 substituted pyrazolopyrimidines as kinase inhibitors |
| 01/02/2008 | CN101098870A Novel fused imidazole derivative |
| 01/02/2008 | CN101098869A 5-heteroaryl thiazoles and their use as p13k inhibitors |
| 01/02/2008 | CN101098858A 吲唑磺酰胺衍生物 Indazole sulfonamide derivative |
| 01/02/2008 | CN101098857A Nitro indazole derivatives |
| 01/02/2008 | CN101098708A Treatment of an intestinal adenoma and/or adenocarcinoma by inhibition of Notch pathway activation |
| 01/02/2008 | CN101098696A Improved dosing regimen of temozolomide for treating cancer based on the patient's mgmt level |
| 01/02/2008 | CN101098692A Therapeutic compounds isolated form CALOMERIA AMARANTHOIDES |
| 01/02/2008 | CN101096680A NDA vaccine eucaryon expression carrier and application in preparation of gene vaccine |
| 01/02/2008 | CN101096671A Blood vessel formation inhibitor HM-X and its preparation method and application |
| 01/02/2008 | CN101096670A siRNA interfering human a-fetoprotein gene and recombinant adenovirus |
| 01/02/2008 | CN101096664A Arginine deacylase covalent ornaments, its manufacturing method and application |
| 01/02/2008 | CN101096656A Helicobacter pylori recombinant VacA monoclonal antibody and uses thereof |
| 01/02/2008 | CN101096384A Preparation method of fused protein for antitumor and application thereof |
| 01/02/2008 | CN101096382A Aglyco products and methods of use |
| 01/02/2008 | CN101096348A New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them |
| 01/02/2008 | CN101096337A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/02/2008 | CN101095957A Medicinal composition including fibroblast growth factor acceptor 2 ó¾ c analogue gene |
| 01/02/2008 | CN101095953A Treating cancer through attracting effect T cell and loss regulating T cell |
| 01/02/2008 | CN101095822A Chinese traditional medicine composition for treating leukemia and method of making the same |
| 01/02/2008 | CN101095713A Sargentgloryvine tetraterpenes macrolide sodium complex agent for injections for treating knub and method for preparing the same |
| 01/02/2008 | CN101095706A Antineoplastic medicine containing Chinese holly water extract or alcohol extract |
| 01/02/2008 | CN101095705A Extract of the Chinese traditional medicine of fruits of Ailanthus altissima and the preparation technics and the use thereof |
| 01/02/2008 | CN101095702A Graininess medicine containing hirsutella.hepia - cordycepsíífungusíípowder and method for preparing the same |
| 01/02/2008 | CN101095701A Flaky medicine containing hirsutella.hepia - cordycepsíífungusíípowder and method for preparing the same |
| 01/02/2008 | CN101095699A Anticancer epiphyte composition and method of making the same |
| 01/02/2008 | CN101095687A Tubeimoside ó± for the preparing of the medicine for resisting the growth, invasion and transfer of the knub |
| 01/02/2008 | CN101095684A Prunol phospholipid complexes and method for preparing the same and the application thereof |
| 01/02/2008 | CN101095672A Novel pharmacy use of medicinal composition |
| 01/02/2008 | CN101095669A Osthole phospholipid complexes and method for preparing the same and application thereof |
| 01/02/2008 | CN101095664A Phosphatide compound of resveratrol compounds and method for preparing the same and the application thereof |
| 01/02/2008 | CN101095660A Docetaxel lyophilization dry emulsion for injections and method for preparing the same |
| 01/02/2008 | CN100359014C Novel epothilones compound and its preparation method and application |
| 01/02/2008 | CN100359004C Natural killer cell for transgenic expression cell chemotactic factors |
| 01/02/2008 | CN100358920C Methods for identifying inducers and inhibitors of propteolytic antibodies, compositions and their uses |
| 01/02/2008 | CN100358919C Mammal prolactin variants |
| 01/02/2008 | CN100358918C Tumour tag and use thereof |
| 01/02/2008 | CN100358917C Tumor tag and the use thereof |
| 01/02/2008 | CN100358910C Glucose phosphonic amide crystals and preparation process and use thereof |
| 01/02/2008 | CN100358892C 7-oxo pyridopyrimidines |
| 01/02/2008 | CN100358891C Pyranones useful as ATM inhibitors |
| 01/02/2008 | CN100358890C 喹唑啉衍生物类激酶抑制剂 Quinazoline derivatives kinase inhibitors |
| 01/02/2008 | CN100358878C Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 01/02/2008 | CN100358869C Carbamate caspase inhibitors and uses thereof |
| 01/02/2008 | CN100358867C Heterocyclic inhibitors of glycogen synthase kinase GSK-3 |
| 01/02/2008 | CN100358595C Safety shield system for prefilled syringe |
| 01/02/2008 | CN100358584C Novel compositions magnetic particles covered with gem-bisphosphonate derivatives |
| 01/02/2008 | CN100358577C Treatment of auto immune diseases with antagonists which bind to B cell surface markers |
| 01/02/2008 | CN100358529C Treatment of hyperproliferative disorders |
| 01/02/2008 | CN100358527C Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 01/02/2008 | CN100358517C Tamoxifen citrate oral disintegrating tablet and its preparation method |
| 01/02/2008 | CN100358512C Pharmaceutical compositions comprising adenosine receptor agonist or antagonist |
| 01/02/2008 | CN100358499C Xiaoaiping dripping pill for treating various cancers and its preparing method |
| 01/02/2008 | CN100358494C Inhalation system |
| 01/01/2008 | US7314940 For therapy and prophylaxis of neurodegenerative disorders related to apoptosis and/or inflammation |
| 01/01/2008 | US7314936 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 01/01/2008 | US7314934 Substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors |
| 01/01/2008 | US7314926 Inhibiting cell proliferation, breast cancer, prostate cancer, cervical cancer, lung cancer, or tumor cells |
| 01/01/2008 | US7314923 The present invention relates to novel oligonucleotide analogues, which exhibit antisense or antigene activity having excellent stability, or exhibit excellent activity as a detection agent (probe) for a specific gene or as a primer |
| 01/01/2008 | US7314914 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 01/01/2008 | US7314889 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 01/01/2008 | US7314885 (4-(4-(2,3-difluorophenyl)-4H-1,2,4-triazol-3-yl)-1H-pyrrol-2-yl)(2H-pyrrol-1(5H)-yl)methanone; anticarcinogenic, antiproliferative and antimetastasis agent; inhibitors of c-Met protein kinase |
| 01/01/2008 | US7314881 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds |
| 01/01/2008 | US7314868 fusing cells; nucleic acid vector comprises a nucleotide sequence encoding a measles virus F glycoprotein and a nucleotide sequence encoding a chimeric measles virus H glycoprotein; nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface |
| 01/01/2008 | US7314754 Polynucleotide encoding the hOT7T175 G protein coupled receptor |
| 01/01/2008 | US7314731 Preparing biopsy of tumorous tissue and monitoring chemosensitivity to anticarcinogenic agents; antitumor agents |
| 01/01/2008 | US7314643 Soft capsule preparation |
| 01/01/2008 | US7314642 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants |
| 01/01/2008 | US7314629 Inducing an immune response towards the HPV-16 Papillomavirus native E7 protein, without simultaneously inducing an immunosuppression; cancers associated with an infection |
| 01/01/2008 | US7314626 Peptide antibiotic conjugate for use in recognition and elimination of infections agents or neoplasms; antitumor agents; bactericides |
| 12/27/2007 | WO2007150002A2 PRODRUGS OF 5-AMINO-3-(3'-DEOXY-β-D-RIBOFURANOSYL)-THIAZOLO[4,5-d] PYRIMIDIN-2,7-DIONE |
| 12/27/2007 | WO2007149935A2 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator |
| 12/27/2007 | WO2007149891A2 Crystalline forms of gemcitabine amide prodrug, compositions and use thereof |
| 12/27/2007 | WO2007149594A2 Modified ribonucleases |
| 12/27/2007 | WO2007149557A1 FUSED [d]PYRIDAZIN-7-ONES |
| 12/27/2007 | WO2007149512A2 Peptide epoxyketones for pr0teas0me inhibition |
| 12/27/2007 | WO2007149451A2 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 12/27/2007 | WO2007149448A2 Pyrazinones as cellular proliferation inhibitors |